Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity.
about
Marine Antimicrobial Peptides: Nature Provides Templates for the Design of Novel Compounds against Pathogenic BacteriaPeptides and Peptidomimetics for Antimicrobial Drug DesignAntiviral mechanisms of human defensinsCytokeratins mediate epithelial innate defense through their antimicrobial properties.Involvement of β-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparumPerspectives for clinical use of engineered human host defense antimicrobial peptidesHuman beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules.Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges.Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool.The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxinStructure-activity relations of myxinidin, an antibacterial peptide derived from the epidermal mucus of hagfishPeptide inhibitors against herpes simplex virus infections.Omics in laboratory medicine.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers.Host defense peptide-derived privileged scaffolds for anti-infective drug discovery.Structural determinants of Neosartorya fischeri antifungal protein (NFAP) for folding, stability and antifungal activity.β-Defensins in the Fight against Helicobacter pylori.Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines.Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility.Microbial Diseases of Bivalve Mollusks: Infections, Immunology and Antimicrobial Defense.Current insights into the role of human β-defensins in atopic dermatitis.Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics.Antimicrobial peptide coatings for hydroxyapatite: electrostatic and covalent attachment of antimicrobial peptides to surfaces.An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule.Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease.β-Defensin 1 plays a role in acute mucosal defense against Candida albicans.Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis.Peptide-lipid interactions: experiments and applications.Structural insights into and activity analysis of the antimicrobial peptide myxinidin.Activity of human beta defensin-1 and its motif against active and dormant Mycobacterium tuberculosis.Expression of recombinant HBD3 protein that reduces Mycobacterial infection capacity.Engineering of a linear inactive analog of human β-defensin 4 to generate peptides with potent antimicrobial activity.Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33.A novel cecropin B-derived peptide with antibacterial and potential anti-inflammatory properties
P2860
Q26746943-8E33E9FE-290E-4A03-B850-836D2F80A7F6Q26799959-49E05DC3-B503-45C4-BD56-3BECB3D5AAAAQ27023010-509264ED-5E69-412A-8D9A-D09E4DB8E744Q29871126-5FECF884-112D-4821-A539-5738A649D355Q30179429-B18D3AE2-B6EA-4940-BAB4-0991F30979C3Q33700825-F248E762-FFE6-494F-8F58-2DA40FA20838Q34737252-E8221DB9-6330-4E59-897C-FF4EF50AA128Q35006475-7A76CAC5-E390-4E4D-A2CE-BA2209C965B3Q35173769-62F3C624-F415-4770-A7CE-94188489B702Q35565673-5D2C7168-67FE-4AEC-B137-BA5E7B1D0D05Q36128939-9F99150A-BA8D-4CF7-A1A9-6686D4B29A74Q36176823-67BFFCD1-59DD-4FC7-A338-94C32C989041Q36587156-C41E93B8-5DAE-4759-95F0-934BC6EE4979Q37250664-CAB934A5-127E-4884-A677-DFF30E943647Q37263518-337A811E-D6B9-4805-92A5-98123E11EA1BQ38079780-B6835DE8-E431-42CF-A854-ECC3D7C5180BQ38141078-2E5671CA-6150-462B-AF9A-845D2549E678Q38260862-1001F175-9842-44AC-831D-594A0351A463Q38542276-C3B69343-CF9A-4A0F-ACE6-0028B6927148Q38721745-1EF1FB49-4D23-436F-8199-015229FDBF88Q38781831-28AE37C0-8A55-4A02-B332-8D206F2A40C6Q39168125-FD3A94F7-26FC-48E6-9421-6F3916AEB8BBQ39203205-E1175904-971B-43D7-B5C6-2DA9B6349A07Q39383339-C4CAF993-1681-4BC9-9308-1C90ED0FC3C1Q39383411-D96CD8E7-4704-403C-A2D2-B143ECD71514Q39435059-5005DE43-392F-4507-AE78-A60130D95EB4Q39447286-A3CA52BC-5682-4023-B76E-B7BFF247C926Q40375650-DEEBB925-13C5-48A6-B997-70FD382D023BQ41033958-5EE3DD88-DB40-473B-B32A-13C384B05972Q41193264-0655B08E-8A33-47B3-944F-24E86DA56D50Q41539981-BCB3DBDC-89F7-4974-B554-6C536A37200CQ41907587-C2DECC0E-1D11-4142-BF04-A2B33B01E759Q42017138-F6942A14-BFC6-43AD-8800-8C96DA478C0EQ42209245-C587A26B-CA1C-469D-91A4-75FD64C321F4Q50259871-F0CE84B3-C4C1-42B6-A117-18CF0376ED00Q52647380-28F090AF-031F-441D-8CD8-B2E4F350AF4AQ53281868-420EA661-D79B-4D1F-AC05-B689CC7B7D8BQ54345768-F8990308-2916-412F-8CA5-7B2AD96B30DCQ57214821-CE0E4C57-D350-4375-99DE-2CA89A24B34A
P2860
Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Novel synthetic, salt-resistan ...... hanced antimicrobial activity.
@ast
Novel synthetic, salt-resistan ...... hanced antimicrobial activity.
@en
type
label
Novel synthetic, salt-resistan ...... hanced antimicrobial activity.
@ast
Novel synthetic, salt-resistan ...... hanced antimicrobial activity.
@en
prefLabel
Novel synthetic, salt-resistan ...... hanced antimicrobial activity.
@ast
Novel synthetic, salt-resistan ...... hanced antimicrobial activity.
@en
P2093
P2860
P356
P1476
Novel synthetic, salt-resistan ...... hanced antimicrobial activity.
@en
P2093
Carlo Pedone
Francesco Salvatore
Gino Naclerio
Giuseppe Castaldo
Marco Cantisani
Mariateresa Vitiello
Massimiliano Galdiero
Olga Scudiero
Rosa Di Noto
Stefania Galdiero
P2860
P304
P356
10.1128/AAC.01550-09
P407
P577
2010-03-22T00:00:00Z